巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    RAPT Therapeutics

    RAPT
    18.030
    0.220
    1.21%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・RAPT Therapeutics - 延遲價格・最後更新於 01/07 12:14
    最高位
    18.480
    最低位
    17.560
    開市價
    --
    前收市價
    18.250
    成交量(千)
    6.59
    成交額(百萬)
    1.01
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    534.53
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    40.670 - 9.855
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    RAPT Therapeutics
    證券代碼
    RAPT.US
    所屬板塊
    Biotechnology
    公司業務
    RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
    發行量
    29591072
    公司總部
    561 Eccles Avenue
    公司網址
    https://www.rapt.com
    公司電話
    +1 650 489-9000
    暫無內容

    關於

    RAPT Therapeutics(RAPT.US)所屬的行業板塊為Biotechnology。
    RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
    詳細公司背景可參考: https://www.rapt.com